Read the docs
TI-2023-05596 Aliases CVE-2023-6078GHSA-h6hc-84g9-qq4q

OS command injection in Dassault Systèmes BIOVIA Materials Studio products

Priority MEDIUM 46CWE-78Published · Updated

Key facts

Attack vector
Network
Privileges required
None
User interaction
None
Attack complexity
Low
Impact type
Code execution
Confidentiality · integrity · availability
High · High · High
Fix status
No fix listed

Attack profile from CVSS 3.1 · NVD. Fix status from CNA. Impact type from CWE-78.

Summary

An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.

Why it matters now

Exploitation None reported CISA SSVC · not in CISA KEV
EPSS 0.01643 76th percentileScored 2026-11-07
Fix No fix listed No fixed version in the sources yet

SSVC decision points

CISA ADP · SSVC 2.0.3

Exploitation
None
Automatable
No
Technical impact
Total

The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.

Affected products

VendorProductAffected versionsFixed inStatusSource
Dassault SystèmesBIOVIA Materials Studio productsBIOVIA 2021 Golden; BIOVIA 2022 Golden; BIOVIA 2023 Golden—No fix listedCNA
  • BIOVIA Materials Studio products VendorDassault Systèmes Affected BIOVIA 2021 Golden; BIOVIA 2022 Golden; BIOVIA 2023 Golden Fixed in — No fix listed CNA

CPE configurations NVD · 1

CPEVersionsRoleVendor
cpe:2.3:a:3ds:biovia_materials_studio:*:*:*:*:*:*:*:*2021 – 2023VulnerableDassault Systèmes
  • cpe:2.3:a:3ds:biovia_materials_studio:*:*:*:*:*:*:*:* Versions 2021 – 2023 Vulnerable ·Dassault Systèmes

Remediation

No fixed version listed by the sources yet.

Timeline

  1. 2026-10-02 Threatist record created from CVE-2023-6078
  2. 2026-10-03 Alias added: GHSA-h6hc-84g9-qq4q

References

Advisory 1

Sources

This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences